Catalase, carbonic anhydrase and other biochemical parameters in esophageal cancers in Turkey

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 1029-1032

  Demir, Halit ^a   Akkus, Zeynel Abidin ^a   Cebi, Aysegul ^b   Cakir, Tahir ^a   Izmirli, Mustafa ^c  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b GIRESUN UNIVERSITY   (Turkey)

^c NONE

Author keywords

Biochemical parameters; Carbonic anhydrase; Catalase; Esophageal cancers

Indexed keywords

EID: 78650682774     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Aebi H (1984). Catalase in vitro. Methods Enzymol, 105, 121-6.
2. Barve A, Khan R, Marsano L, et al (2008). Treatment of alcoholic liver disease. Ann Hepatol, 7, 5-15.
3. Becker BF (1993). Towards the physiological function of uric acid. Free Radic Biol Med, 14, 615-31.
4. Chang AC, Ji H, Birkmeyer NJ, et al (2008). Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg, 85, 424-9.
5. Cooper EH, Stone J (1979). Acute phase reactant proteins in cancer. Adv Cancer Res, 30, 1-44.
6. De Zoysa, M Lee J (2007). Two ferritin subunits from disk abalone (Haliotis discus discus): Cloning, characterization and expression analysis. Fish Shellfish immunol, 23, 624-35.
7. Glantzounis GK, Tsimoyiannis EC, Kappas AM, et al (2005). Uric acid and oxidative stress. Curr Pharm Des, 11, 4145-51.
8. Feagins LA, Zhang HY, Hormi-Carver K, et al (2007). Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells. Am J Gastroenterol, 102, 10-20.
9. Gockel I, Dirksen K, Messow CM, et al (2006). Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol, 12, 3746-50.
10. Hao J, Liu B, Yang CS, et al (2009). Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice. BMC Gastroenterol, 9, 59.
11. Hwang TS, Choi HK, Han HS (2007). Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa. Eur J Surg Oncol, 33, 474-9.
12. Jimenez P, Piazuelo E, Sanchez MT, et al (2005). Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J Gastroenterol, 11, 2697-703.
13. Karmen A, Wroblewski F, Ladue JS (1955). Transaminase activity in human blood. J Clin Invest, 34, 126-31.
14. Kawamura T, Ohisa Y, Abe Y, et al (1992). Plasma lipid peroxides in the operation of esophageal cancer. Rinsho Byori, 40, 881-4.
15. Kimm H, Kim S, Jee SH (2010). The Independent effects of cigarette smoking, alcohol consumption, and serum aspartate aminotransferase on the alanine aminotransferase ratio in Korean men for the risk for esophageal cancer. Yonsei Med J, 5, 310-7.
16. Koukourakis MI, Giatromanolaki A, Sivridis E, et al (2003). Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer, 89, 877-85.
17. Maekawa M (1988). Lactate dehydrogenase isoenzymes. J Chromatogr, 429, 373-98.
18. Markert CL (1963). Lactate dehydrogenase isozymes: Dissociation and recombination of subunits. Science, 140, 1329-30.
19. McManus DT, Olaru A, Meltzer SJ (2004). Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res, 64, 1561-9.
20. McCarty MF (2001). Prospects for glucose-rescued hypoglycemia as acancer therapy. Med Hypotheses, 56, 283-9.
21. Miki S, Iwano M, Miki Y, et al (1989). Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett, 250, 607-10.
22. Monya K, Nakagawa K, Santa T (2001). Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res, 61, 4365-70.
23. Nozoe T, Saeki H, Sugimachi K (2001). Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg, 182, 197-201.
24. Olyaee M, Sontang S, Salan W, et al (1995). Mucosal reactive oxygen species production in oesophagitis and Barrett's esophagus. Gut, 37, 168-73.
25. Orino K, Lehman L, Tsuji Y, et al (2001). Ferritin and the response to oxidative stress. Biochem J, 357, 241-7.
26. Ozer J, Ratner M, Shaw M, et al (2008). The current state of serum biomarkers of hepatotoxicity. Toxicol, 245, 194-205.
27. Rickli EE, Ghazanfar SAS, Gibbons BH, et al (1964). Carbonic anhydrase from human erytrocytes. Preparation and properties of two enzymes. J Biol Chem, 239, 1065-78.
28. Riedler GF, Zollinger P, Schimit M (1975). Changes in the blood picture in liver disease. Scweiz Med Wochenschr, 105, 1593.
29. Sevelius E (1995). Diagnosis and prognosis of chronic hepatitis and cirrhosis in Dogs. J Small Amin Prac, 36, 521-8.
30. Shimada H, Nabeya Y, Okazumi S, et al (2003). Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma. Dis Esophagus, 16, 102-6.
31. Stamp DH (2006). Bile acids aided by acid suppression therapy may be associated with the development of esophageal cancers in westernized societies. Med Hypotheses, 66, 154-7.
32. Skrzydlewska E, Kozuszko B, Sulkowska M, et al (2003). Antioxidant potential in esophageal, stomach and colorectal cancers. Hepatogastroenterology, 50, 126-31.
33. Sly WS, Hu PY (1995). Human carbonic anhydrases and carbonic anhydrase deficiencies. Ann Rev Biochem, 64, 375-401.
34. Staub M (1999). Uric acid as a scavenger in oxidative stress. Orv Hetil, 140, 275-9.
35. Tekman S, Oner N (1994). Genel biyokimya, fakulteler matbaasi, istanbul.
36. Tilanus HW (1995). Changing patterns in the treatment of carcinoma of the esophagus. Scand J Gastroenterol Suppl, 212, 38-42.
37. Uǧur-Chousein EG (2005). Tuberkuloz hastalarda urik asit seviyelerin degerlendirilmesi. (uzmanlik tezi. basilmis), surreyya paşa gogus kalp ve damar hastaliklari egitim hastanesi, sosyal sigortalar kurumu, istanbul.
38. Turkyilmaz A, Eroglu A, Aydin Y, et al (2009). Survival in esophageal cancer patients with hematogenous distant organ metastases. Turk J Med Sci, 39, 415-21.
39. Wetscher GJ, Hinder RA, Bagchi D, et al (1995). Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg, 170, 552-7.
40. Wiseman H, Halliwel B (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J, 93, 113-20.
41. Wong RK, Malthaner RA, Zuraw L, et al (2003). Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys, 55, 930-42.
42. Zavada J, Zavadova Z, Pastorekova S, et al (1993). Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer, 54, 268-74.
43. Zhou Z, Liu J, Song Z, et al (2008). Zinc supplementation inhibits hepatic apoptosis in mice subjected to a long-term ethanol exposure. Exp Biol Med (Maywood), 233, 540-8.